ABRDN PLC – Ligand Pharmaceuticals Incorporated Transaction History
ABRDN PLC portfolio value:
$38.09M
portfolio value
ABRDN PLC quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.21% | 13.77K shares | -147K | $86.11 | 442.35K |
| Q2 2022 | share | Increase | +27.93% | 93.58K shares | 555K | $89.22 | 428.58K |
| Q1 2022 | share | Decrease | -7.58% | -27.46K shares | -18.30M | $112.49 | 335.00K |
| Q4 2021 | share | Increase | +1.20% | 4.30K shares | 6.08M | $156.16 | 362.46K |
| Q3 2021 | share | Decrease | -11.73% | -47.61K shares | -3.33M | $139.32 | 358.16K |
| Q2 2021 | share | Increase | 0.00% | 405.77K shares | 53.23M | $131.19 | 405.77K |
| Q1 2021 | share | Decrease | -52.73% | -194.59K shares | -10.13M | $152.45 | 174.48K |
| Q4 2020 | share | Increase | +87.36% | 172.08K shares | 17.95M | $99.45 | 369.08K |
| Q3 2020 | share | Increase | 0.00% | 196.99K shares | 18.77M | $95.32 | 196.99K |